Key stats
About PIVOTAL THERAPEUTI
Sector
Industry
CEO
Rachelle MacSweeney
Website
Headquarters
Concord
Founded
2010
FIGI
BBG002QK5QR0
Pivotal Therapeutics, Inc. is a pharmaceutical company, which engages in the optimization of Omega-3 therapy for cardiovascular disease and overall health. The firm’s products include Benefishial, Omazen, and Vascazen. The company was founded by Eugene G. Bortoluzzi, Rachelle MacSweeney and George Jackowski on October 1, 2010 and is headquartered in Concord, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PVTTF is 0.0018 USD — it has increased by 179.90 K% in the past 24 hours. Watch PIVOTAL THERAPEUTI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PIVOTAL THERAPEUTI stocks are traded under the ticker PVTTF.
PVTTF stock is 99.94% volatile and has beta coefficient of 0. Track PIVOTAL THERAPEUTI stock price on the chart and check out the list of the most volatile stocks — is PIVOTAL THERAPEUTI there?
No, PVTTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PVTTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PIVOTAL THERAPEUTI stock right from TradingView charts — choose your broker and connect to your account.
PVTTF reached its all-time high on Apr 3, 2012 with the price of 0.3800 USD, and its all-time low was 0.000001 USD and was reached on Feb 18, 2022. View more price dynamics on PVTTF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PIVOTAL THERAPEUTI technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PIVOTAL THERAPEUTI stock shows the sell signal. See more of PIVOTAL THERAPEUTI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.